Trial
NCT06094426
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Grit Biotechnology
Collaborators
—
Condition
Solid Tumor
Intervention
GT316
Why stopped
The study was terminated from a business perspective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-29